I am/have/had
I am looking for
Advanced Filters
Found 356 clinical trials
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Giving CPX-351 and/or gilteritinib with standard chemotherapy may work better in treating patients with acute myeloid leukemia compared to standard chemotherapy alone.
residual leukemic cells
blood cell count
mental retardation
chemotherapy drug
gemtuzumab
- 0 views
- 2 annotations
- 19 Feb, 2024
- 1 location
